When he needed a CPAP machine for sleep apnea about 18 months ago, he ended up in a program that supported him through some dietary changes to help address the apnea, along with his high blood pressure and cholesterol levels, and pre-diabetic blood sugar status
PNPLA3(148M) is a gain-of-function mutation that promotes hepatic steatosis by inhibiting ATGL-mediated triglyceride hydrolysis
Marbury TC, Flint A, Jacobsen JB, Karsbl JD
Between courses, gaps of 3 to 6 months are standard
Serious complications are rare, but you should report persistent symptoms or signs of pancreatitis to your provider immediately
Available from Accessed 23 June 2020 Kaul U, Parmar D, Manjunath K et al (2019) New dual peroxisome proliferator activated receptor agonist-Saroglitazar in diabetic dyslipidemia and non-alcoholic fatty liver disease: integrated analysis of the real world evidence